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Background: Long intervening non-coding RNAs (lincRNAs) are a recently discovered subclass of non-coding RNAs.
LincRNAs are expressed across the mammalian genome and contribute to the pervasive transcription phenomenon.
They display a tissue-specific and species-specific mode of expression and are present abundantly in the brain.
Results: Here, we report the expression patterns of oligodendrocyte maturation-associated long intervening
non-coding RNA (OLMALINC), which is highly expressed in the white matter (WM) of the human frontal cortex
compared to the grey matter (GM) and peripheral tissues. Moreover, we identified a novel isoform of OLMALINC
that was also up-regulated in the WM. RNA-interference (RNAi) knockdown of OLMALINC in oligodendrocytes, which
are the major cell type in the WM, caused significant changes in the expression of genes regulating cytostructure,
cell activation and membrane signaling. Gene ontology enrichment analysis revealed that over 10% of the top 25
up- and down-regulated genes were involved in oligodendrocyte maturation. RNAi experiments in neuronal cells
resulted in the perturbation of genes controlling cell proliferation. Furthermore, we identified a novel cis-natural
antisense non-coding RNA, which we named OLMALINC-AS, which maps to the first exon of the dominant isoform
of OLMALINC.
Conclusions: Our study has demonstrated for the first time that a primate-specific lincRNA regulates the expression of
genes critical to human oligodendrocyte maturation, which in turn might be regulated by an antisense counterpart.
Keywords: Long intervening non-coding RNA, OLMALINC, Human brain, Frontal cortex, White and grey matter,
Antisense RNABackground
There is a growing comprehension that the majority of
the transcribed genome does not code for proteins but
comprises a variety of non-coding RNAs of different
properties, such as length, as well as functionality in
transcriptional and epigenetic control [1]. In particular,
long non-coding RNAs (lncRNAs) seem to be a very
recent evolutionary development, and this is supported by
the observation that primates, and humans in particular,* Correspondence: m.janitz@unsw.edu.au
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A subcategory of lncRNAs, termed long intervening
non-coding RNAs (lincRNAs), show a tissue-specific
mode of expression and substantially contribute to
the pervasive transcription that is observed in the
mammalian genome. LincRNAs are defined as intervening
(relative to the current gene annotations) transcripts that
are longer than 200 nucleotides in length and lack
protein-coding capacity [2,3].
The role of lincRNAs is thought to be in gene regulation,
and in the brain it has been proposed that non-coding
RNAs may play a role in regulating axon myelination in
WM and glial cell differentiation [4]. It is thought thatis is an Open Access article distributed under the terms of the Creative
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occur within the genome, such as increasing or decreasing
mRNA levels through sequestration or stabilization, thus
regulating the transcription of target genes. Such a process
is of the utmost importance in the development of the
complicated array of cells that is observed within the brain.
There is a growing body of evidence that the human
brain, as the most complex organ in the body, is the
richest source of lncRNAs, reflecting the demand for
highly complex control mechanisms for the differenti-
ation and development of numerous cell types, including
neurons and oligodendroglia [4]. Indeed, our recent
RNA sequencing (RNA-Seq) study has revealed vast
differences between the transcriptomes of the GM and
WM in the human superior frontal cortex [5]. While not
unexpected, given the differences in cell type populations
within these two structures, this study has demonstrated
that a significant number of annotated and unidentified
lincRNAs are expressed at high levels and disparate
quantities between GM and WM.
One of the most noticeable examples of differentially
expressed lincRNAs between WM and GM was linc00263
[5]. Compared to most lincRNAs, which remain at low
expression levels, i.e. < 2 fragments per kilobase of exon
per million fragments mapped (fpkm), linc00263 was
expressed at 16.2 and 71.5 fpkm in GM and WM,
respectively [5]. The high levels of expression in WM
suggest that linc00263 may have a functional importance in
oligodendrocytes, which constitute the majority of cells in
the WM. Here, we validated the differential expression of
linc00263 in GM and WM using RT-qPCR. Furthermore,
we performed a comparative analysis of linc00263 using
vertebrate genomes and found that this gene is specific
to primates. Finally, RNAi knockdown of linc00263 in
human neuronal and oligodendrocyte cell lines
followed by transcriptome sequencing demonstrated
that silencing of linc00263, which we renamed to
OLMALINC (oligodendrocyte maturation-associated
long intervening non-coding RNA), results in coordinated
changes in the expression of genes controlling the cyto-
skeleton and maturation of glial cells.
Results
OLMALINC is highly expressed in the white matter of the
human frontal cortex
In our recently published global analysis of the tran-
scriptome of the WM and GM of the human frontal
cortex, we detected 4.4-fold overexpression of OLMALINC
in WM versus GM [5]. The overall expression of OLMA-
LINC was 16.2 fpkm in GM tissue and 71.5 fpkm in WM
(Additional file 1: Figure S1A). RNA-Seq analysis revealed
that OLMALINC is expressed as two isoforms (Figure 1).
The alignment pattern of RNA-Seq reads in the WM sam-
ples shows equal amounts of reads aligning to each exon ofOLMALINC-002 (Figure 1). This read distribution excludes
the possibility of the long terminal repeat (LTR) element,
that covers exon 3, might artificially inflate the calculated
expression level of OLMALINC. Neither of the isoforms
represented OLMALINC-001, which is annotated in
Ensembl [Ensembl ID: ENSG00000235823]. The most
highly expressed transcript in our comparative analysis
represented the NCBI annotated isoform [NCBI ID:
NR_026762.1], which for clarity, we called OLMALINC-002.
The isoform is 988-nucleotides (nts) long, consists of
three exons (Figure 1), and is overexpressed 4.5-fold
in WM (62.5 fpkm) compared to GM (14 fpkm)
(Additional file 1: Figure S1B). Thus, OLMALINC-002
is a major contributor to the observed overexpression
of the OLMALINC gene in WM. The second alternatively
spliced isoform was not annotated in any of the reference
databases. We named this novel isoform OLMALINC-003.
It is composed of two exons that form a 1517-nts-long
transcript (Figure 1). This novel transcript does not
encode any protein, as determined by an open read-
ing frame (ORF) finder. OLMALINC-003 is expressed
at residual levels in GM (1.6 fpkm) and 10 fpkm in
WM (Additional file 1: Figure S1B).
To confirm the specificity of the short sequence read
alignment and assembly of the data, both OLMALINC
isoforms were reverse transcribed and amplified using
isoform specific primers, and the PCR products were
Sanger sequenced. Sequence alignment of the annotated
isoform and the sequence extracted from the RNA-Seq
data for the novel isoform to the reference genome
confirmed the sequence specificity of the RT-PCR results
(Additional file 2: Figure S2A and B).
Next, we validated the differential expression patterns
of the OLMALINC using RT-qPCR of independent sets
of samples representing the GM and WM of the frontal
cortex. The high expression of OLMALINC, including
both isoforms, was confirmed (Figure 2), with a 12.05-fold
higher expression level in WM (p-value< 0.05). The
OLMALINC primers, used for RT-qPCR, spanned
exons 2 and 3 of OLMALINC-002 and exons 1 and 2
of OLMALINC-003. This primer design ruled out the
possibility of the high FPKM value attributed to
OLMALINC by RNA-Seq as a result of additional
alignment of reads to the LTR element that covers a
large portion of the final exon in both OLMALINC
isoforms (Figure 1).
Comparative sequence analysis and expression of
OLMALINC in mammals
Sequence conservation level of OLMALINC locus was ana-
lyzed using blastn searches, DNA dot plots (https://www.
sanger.ac.uk/resources/software/seqtools/) and chain blastz
alignments on the UCSC genome browser (https://genome.
ucsc.edu/). In primates, homology was detected to all
Figure 1 Genomic context splice of variants and genomic features of OLMALINC. Track 1 represents the chromosomal positioning of
OLMALINC. Track 2 shows OLMALINC in genomic context. OLMALINC is located downstream of the gene stearoyl-CoA desaturase (delta-9-desaturase)
(SCD) and up-stream of wingless-type MMTV integration site family, member 8B (WNT8B). Track 3 is a schematic representation of the exon/intron
structure of the OLMALINC-001, −002 and −003 isoforms as well as OLMALINC-AS. Track 4 is a schematic of the repeat elements that appears in this
region of the genome including long terminal repeats LTR2, LTR7B and HERVH-int. A LTR 7B over laps with a large portion of the final exon of
OLMALINC-002 and OLMALINC-003. Track 5 show the read alignment in the WM samples carried out by TopHat, demonstrating that the repeat
elements have not artificially inflated the RNA-Seq fpkm values.
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rhesus monkey. In bushbaby, marmoset, mouse, elephant,
opossum and platypus homology was only observed with
human exon 1 (Figure 3), and in each case in the same
genomic context (downstream of the SCD gene). The
UCSC phyloP base-wise conservation across 100 vetebrates
shows a peak in conservation 5′ of OLMALINC-001
exon 1, suggesting a possible conserved promoter region
(Additional file 3: Figure S3).
Analysis of published RNA-Seq data [6,7] revealed
expression of all exons in chimpanzee and orangutan
brain, although relative expression of exon 3 was lower
than in human (Additional file 4: Figure S4). In gorilla
brain, only expression of exon 1, and neighboring re-
gions (perhaps the antisense transcript), was detected.
RNA-Seq reads did not map to expected exons in any
other species examined (Additional file 4: Figure S4),
suggesting that OLMALINC-001 is not expressed out-
side of great apes. This information is summarized in
Figure 3.OLMALINC expression profiles in non-brain tissues
To determine whether OLMALINC was likely to be
brain-specific or commonly expressed in all tissues, a
meta-analysis was performed. This analysis utilized
publicly available RNA-Seq datasets from the Illumina
Transcriptome BodyMap 2 project, which included
samples from 16 human tissues, including brain,
using humans of varying ages and sex. The 15 tissues
in the Illumina data sets were compared with the
brain transcriptome data. The non-brain tissues comprised
liver, kidney, heart, lung, skeletal muscle, breast, adrenal,
thyroid, prostate, ovary, testes, adipose, colon, lymph node,
and white blood cells. The analysis was carried out using
the Tuxedo protocol [8] and showed that brain expression
level of OLMALINC was higher than the expression levels
in any other tissue type (Figure 4 and Additional file 5:
Figure S5). Liver, ovary and breast tissue had the next
highest levels of OLMALINC expression; these levels
were approximately half of the OLMALINC expression
seen in the brain. On average OLMALINC was expressed
Figure 4 Comparative analysis of the OLMALINC expression
levels in brain and 15 other human tissues. The bar graph shows
Figure 2 RT-qPCR validation of the OLMALINC gene expression
patterns in GM and WM samples. This boxplot shows OLMALINC was
up-regulated 12.05-fold in WM when compared to GM (p-value < 0.05).
Mills et al. Molecular Brain  (2015) 8:2 Page 4 of 127.5-fold higher in the brain when compared to other
sources of tissue. To validate the expression levels from the
Illumina Transcriptome BodyMap 2 project, the expression
level of OLMALINC was analysed in another publicly avail-
able RNA-Seq dataset produced by The Human Protein
Atlas project. The tissue types assessed were brain,
liver, kidney, skin and bone marrow (Additional file 5:
Figure S5). OLMALINC was expressed at 3-fold higherFigure 3 Summary of homology and expression of OLMALINC
(UCSC uc001kqz.4) exons in representative vertebrate
genomes. Homology and expression of all three exons is only detected
in human and chimpanzee. Exons 2 and 3 are not detected outside of
old world monkeys. There is low expression of exon 3 in orangutan.
Outside of great apes there is no expression of any exon. ND = no data.
U = homology was only detected in the UCSC genome browser and
not by any other method (blastn/blat/dotplots). - = no expression
detected. + = expression detected. ? = low levels of expression detected.
the difference in expression levels of OLMALINC in varying tissues
compared to the brain. The RNA-Seq datasets used for this analysis
were taken from Illumina’s BodyMap2 project. The brain has at least
a greater than 1.9x expression level of OLMALINC than any other tissue.
The y-axis is expression in fpkm.level in the brain when compared to liver and on aver-
age 20-fold higher than the other tissue types. Usage of
this independent set of tissue-specific transcriptome se-
quence data thus corroborates the pattern seen in the
Illumina dataset.
The OLMALINC locus co-expresses cis-natural antisense
RNA
Recently, we performed strand-specific RNA-Seq analysis
of combined RNA samples derived from the GM and WM
tissue from the frontal cortex (Mills et al., unpublished
data). Bioinformatics analysis of this dataset revealed the
presence of an antisense RNA that mapped to the first exon
of the OLMALINC-002 isoform (Figure 1). This antisense
transcript is 488-nts long, consists of one exon and is
expressed at 18 fpkm in the whole brain tissue. We named
this RNA OLMALINC-AS to emphasize its cis-natural fea-
ture in regard to its overlap with the OLMALINC locus.
To validate the sensitivity of the strand-specific RNA-Seq
analysis, we amplified and Sanger sequenced a fragment
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Alignment to the reference genome confirmed expression
of the OLMALINC-AS in the human frontal cortex
(Additional file 2: Figure S2C).
To further explore the pattern of OLMALINC-AS
expression in specific histological structures of the
cortex, we quantified the levels of this transcript in
GM and WM samples using RT-qPCR. Figure 5 shows
11.7-fold up-regulation (p-value = 0.07) of OLMALINC-AS
in WM. This fold-change did not reach the p-value cut-off
level for statistical significances.
OLMALINC knockdown in oligodendrocytes and neurons
To provide insight into the influence of OLMALINC on
gene expression and regulation of transcription in cortical
tissue, we performed RNAi-driven silencing of OLMALINC
in the human MO3.13 oligodendrocytes and SK-N-SH neu-
rons. The efficiency of the down-regulation of OLMALINC
expression in the two cell lines was estimated by RT-qPCR.
We were able to specifically reduce OLMALINC levels in
oligodendrocytes and neurons by 4.5- and 3.5-fold, respect-
ively (p-values < 0.05) (Additional file 6: Figure S6).
Next, to assess the impact of OLMALINC depletion at
the level of the whole transcriptome, we performed
RNA-Seq analysis on the OLMALINC silenced cells. In
MO3.13 oligodendrocytes, 81 genes were up-regulated
and 41 were down-regulated (Additional file 7: Table S1).
Notably, RNAi-driven reduction of OLMALINC expres-
sion led to twice as many genes being up-regulated as
down-regulated in these cells.
In SK-N-SH neurons, 29 genes showed a significant
increase in expression after knockdown of both
OLMALINC isoforms, whereas 17 genes were down-
regulated (Additional file 8: Table S2). Again, amongstFigure 5 Quantification of OLMALINC-AS in GM and WM of the
frontal cortex. This boxplot shows OLMALINC-AS was up-regulated
11.7-fold in WM (p-value = 0.07).the genes affected by OLMALINC knockdown, nearly
twice as many genes showed increased rather than de-
creased expression in neurons.
OLMALINC knockdown affects genes regulating cell
activation and membrane signaling in oligodendrocytes
Gene ontology analysis of differentially expressed genes
(DEGs) and differentially expressed isoforms (DEIs)
(Additional file 9: Table S3) in oligodendrocytes revealed
two superclusters of genes and isoforms that were involved
in the regulation and maintenance of cytostructure and cel-
lular adhesion. Moreover, there were four individual clusters
related to heart development, cell activation, cell surface
receptor-linked signal transduction and positive regulation
of cell adhesion (Figure 6). Overall 56 DEGs and DEIs were
clustered in the pathway analysis, comprising 34% of the
162 unique DEGs and DEIs that underwent analysis.
Interestingly, amongst the top 25 genes that were
up- and down-regulated as a result of OLMALINC silen-
cing in oligodendrocytes (Additional file 7: Table S1), 12
genes contributed to the pathway clusters that were linked
to the regulation of cell activation and cell surface receptor-
linked signal transduction. In contrast, only 2 of the top 25
DEGs contributed to the cytostructure supercluster, and
none contributed to the cell adhesion supercluster (Table 1).
Several genes of the subset, that are shown in Table 1,
caught our attention due to their involvement in the physi-
ology of oligodendrocytes. The expression profiles for these
selected genes are shown in Figure 7A.
The histone deacetylase 9 (HDAC9) was up-regulated 4.1-
fold, after knockdown of OLMALINC. The protein product
of this gene belongs to class II Hdacs and is expressed
mainly in post-mitotic, mature neurons in the murine cere-
bral cortex [9,10]. Studies of HDAC9 have revealed its asso-
ciation with medulloblastoma [11] and schizophrenia [9].
SRY (Sex-Determining Region Y)-Box 4 (SOX4) was
up-regulated 2.8-fold in OLMALINC-depleted oligodendro-
cytes. SRY (Sex-Determining Region Y) (Sox) proteins of
group C are strongly expressed in the developing nervous
system and have been associated with the maturation of
neurons and glia. Prolonged SOX4 expression in cells of the
oligodendrocyte lineage is incompatible with the acquisition
of a fully mature phenotype, which indicates that the
presence of SOX4, and possibly SRY (Sex-Determining
Region Y)-Box 11 (SOX11), in oligodendrocyte precursors
may normally prevent premature differentiation. SOX4
transgenic mice develop the full spectrum of phenotypic
traits that are associated with severe hypomyelination dur-
ing the first postnatal weeks. In these mice, myelin gene
expression is severely reduced, and myelin dramatically
thinned in several central nervous system (CNS) regions
[12]. SOX4 expression counteracts the differentiation
of radial glia and must be down-regulated before full
maturation can occur [13].
Figure 6 Enrichment map of the Gene Ontology clusters derived from the DEGs and DEIs in oligodendrocytes following silencing of
OLMALINC. The size of the node relates to the number of genes in each term. Lack of branching in the bottom clusters indicates that genes
contributing to these clusters are not present in other clusters and thus are unique for particular pathway.
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down-regulated 3.1-fold in RNAi-treated MO3.13 oli-
godendrocytes. In Schwann cells, GPR126 controls
proper development and myelination [14]. A mutation
in GPR126 causes severe congenital hypomyelinatingTable 1 Expression levels for selected DEGs enriched in gene
oligodendrocytes
Gene Chr. Description GO Clusters
SAA1 chr11 Serum amyloid A1 Cell activation
IL7R chr5 Interleukin 7 receptor Cell activation, cell s
receptor linked sign
APLN chrX Apelin Cell surface recepto
signal transduction
GPR126 chr6 G protein-coupled receptor 126 Cell surface recepto
signal transduction
CXCL5 chr4 Chemokine (C-X-C motif) ligand 5 Cell surface recepto
signal transduction
AXL chr19 AXL receptor tyrosine kinase Cell surface recepto
signal transduction
ANXA1 chr5 Annexin A1 Cell surface recepto
signal transduction
COL3A1 chr2 Collagen, type III, alpha 1 Cell activation, cell s
linked signal transd
SOX4 chr6 SRY (sex determining region Y)-box 4 Cell activation, cell s
linked signal transd
EGR1 chr5 Early growth response 1 Cell activation
HDAC9 chr7 Histone deacetylase 9 Cell activation
WIPF3 chr7 WAS/WASL interacting protein
family, member 3
Cytostructure super
TRIM63 chr1 Tripartite motif containing 63,
E3 ubiquitin protein ligase
Cytostructure super
WNT11 chr11 Wingless-type MMTV integration
site family, member 11
Cell surface recepto
transduction
Chr. - chromosome.peripheral neuropathy in mice and the expression of
differentiated Schwann cell markers [15].
AXL receptor tyrosine kinase (AXL) is a member of
the Tyro3-Axl-Mer (TAM) receptor tyrosine kinase
subfamily and was down-regulated 2.5-fold in our RNAiontology analysis following OLMALINC silencing in
FPKM Control FPKM RNAi Fold Change q-value
12.64 2.20 −5.73 0.0014
urface
al transduction
1.60 0.42 −3.83 0.0194
r linked 17.51 5.38 −3.25 2.99E-07
r linked 2.67 0.88 −3.04 0.0116
r linked 8.84 2.97 −2.98 4.01E-04
r linked 4.23 1.75 −2.42 0.0114
r linked 4.80 2.06 −2.33 4.41E-04
urface receptor
uction
380.21 191.13 −1.99 0.0396
urface receptor
uction
11.85 33.56 2.83 6.13E-11
1.81 5.41 2.99 3.92E-06
0.83 3.33 4.02 0.0486
cluster 0.79 3.44 4.37 4.09E-08
cluster 0.35 1.59 4.62 0.0128
r linked signal 0.13 0.93 7.38 0.0439
Figure 7 Expression levels of selected DEGs in OLMALINC-depleted
oligodendrocytes (A) and neurons (B). In oligodendrocytes the EGR1,
HDAC9 and SOX4 were all up-regulated after RNAi of OLMALINC. AXL
and GPR126 was down-regulated in oligodendrocytes after RNAi of
OLMALINC. The expression levels are in fpkm as calculated by RNA-Seq.
In neurons CASP3, SOX2 and SOX4 were up-regulated after RNAi of
OLMALINC. Level of significance: *q-value < 0.05, **q-value < 0.02,
***q-value < 0.01.
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the nervous system, including oligodendrocytes [16]. It has
been shown that growth arrest-specific 6 (Gas6), a ligand
for the tyro3/Axl/Mer (TAM) receptors, can affect the se-
verity of demyelination in mice, and a loss of signaling via
Gas6 leads to decreased oligodendrocyte survival and in-
creased microglial activation during cuprizone-induced de-
myelination [17]. Gas6 significantly increased myelinationin a dose-dependent manner, suggesting that TAM receptor
signaling could be directly involved in myelination by
oligodendrocytes [18].
Early growth response gene (EGR1) is a zinc-finger
transcription factor that was 3-fold up-regulated in
OLMALINC-silenced oligodendrocytes. EGR1 down-
regulation is critical for oligodendrocyte progenitor cell
differentiation, and the gene was recently included in a
de-repression model of oligodendrocyte lineage progression
that relied on the concurrent down-regulation of several
inhibitors of differentiation [19]. The expression pattern of
selected genes, described above, was confirmed in an
independent OLMALINC silencing experiment using
individual siRNAs followed by RT-qPCR analysis
(Additional file 10: Figure S7).
The cell proliferation pathway is affected by knockdown
of OLMALINC in neurons
GO enrichment analysis of genes whose expression had
been affected by OLMALINC knockdown in neurons
grouped GO terms for cell proliferation into a single clus-
ter. This cluster was composed of 11 genes that comprised
24% of the all DEGs resulting from OLMALINC knock-
down in neurons (Additional file 11: Table S4). Several
genes within this subset have been previously described to
be involved in neuronal biology.
SRY (Sex-Determining region Y)-box 2 gene (SOX2)
was 1.8-fold up-regulated following OLMALINC knock-
down. Sox2 plays a role in the maturation and survival of
embryonic and adult neurons, and Sox2 expression is high
in undifferentiated neurons, but declines upon differenti-
ation [20]. Sox2 deficiency results in decreased precursor
cell proliferation and the generation of new neurons in
adult mouse neurogenic regions [21].
Caspase-3 (CASP3) was up-regulated 1.6-fold following
knockdown of OLMALINC. CASP3 is a key mediator of
apoptosis in neuronal cells. The functions of non-apoptotic
caspase-3 in neuronal cells include synaptic plasticity,
dendrite pruning, as well as learning and memory
processes [22].
Finally, SOX4, which was up-regulated 1.8-fold in neu-
rons, promotes neuronal differentiation and has a central
regulatory role during neuronal maturation. It mechanis-
tically separates cell cycle withdrawal from the establish-
ment of neuronal properties [23]. Figure 7B presents
differences in the expression levels of the SOX2, CASP3
and SOX4 genes as a result of OLMALINC silencing.
Discussion
This study shows that OLMALINC is overexpressed in
the human brain compared to peripheral tissue and that
WM is a major source of this overexpression. Moreover,
silencing of OLMALINC in oligodendrocytes and neurons
affects the expression of functionally related gene sets.
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sense counterpart, OLMALINC-AS, which shows a similar
expression pattern, i.e., up-regulation in WM compared to
GM. Such co-expression of sense and antisense RNAs
with overlapping loci has been previously observed in
the case of the BACE1 mRNA and its natural antisense
non-coding partner BACE1-AS [24]. Comparative analysis
of the OLMALINC sequence demonstrates its unique
expression in primates.
Recent genome-wide surveys on lincRNAs allow us to
draw some general observations about this particular
RNA species [25]. First, it has been suggested that most
lincRNAs are expressed at low levels, usually below 2
fpkm. In contrast to this observation, OLMALINC and
its antisense counterpart, OLMALINC-AS, remain at
levels of at least 16.2 fpkm and reach 71.5 fpkm in WM.
Moreover, our meta-analysis of OLMALINC expression
in peripheral tissues revealed at least 1.9-fold higher
expression of this transcript in brain when compared
to 15 other cell types of the body. Indeed, lincRNAs
have also been shown to exhibit tissue-specific patterns in
model organisms such as zebrafish [26]. In particular, the
overexpression of OLMALINC in the WM corroborated
the outcome of OLMALINC silencing, which affected a
number of genes involved in oligodendrocyte maturation
(see below).
Our comparative analysis of the OLMALINC sequence
with vertebrate genomes revealed a remarkably high
degree of conservation in great ape and old world monkey
genomes (Figure 3). In all other mammal species
examined only homology with exon 1 was observed.
There was also evidence for conservation of the
region 5′ of exon 1, which was detected as far back
as opossum, and even platypus (Figure 3). Although
all exons are present in old world monkeys, detectable
expression of OLMALINC (and its antisense) was only
observed in great apes, with exon 3 under expressed
outside of humans (Additional file 4: Figure S4). Loss of
expression of exons 2 and 3 in gorilla must have occurred
after divergence from the human/chimp lineage.
These findings suggests that the building blocks for
OLMALINC exon 1 are ancient (>200 mya, being com-
mon to all mammals), whereas exons 2 and 3 only arose
in the ancestor of old world moneys (~30-45 mya) [27].
The evolution of exons 2 and 3 was followed by the
expression of OLMALINC in at least the Hominidae
ancestor (>17 mya), with further specialization (high
expression of exon 3) only humans (<6 mya). Although the
original building blocks of OLMALINC appear ancient, its
recently evolved expression suggests that it is a young gene.
Indeed, less than 6% of zebrafish lincRNAs have detectable
sequence conservation with mouse or human lincRNAs
[28]. Moreover, merely 12% of the human and mouse lincR-
NAs are conserved in other species [29,30].It has been previously suggested that lincRNAs tend to
act in cis, thus affecting genes located in a 10-300-kb vicin-
ity of the particular lincRNA locus [31,32]. Interestingly, we
have not observed elevated expression of the protein-
coding genes located in the 300-kb vicinity of the
OLMALINC locus (data not shown), which is in contrast
one study [33], but corroborates observations of others
showing that only 3% of the human lincRNAs have expres-
sion profiles correlated with their neighboring genes [34].
Comparative analysis of the OLMALINC sequence
corroborated earlier observations on its fast evolution
[29,30]. Indeed, OLMALINC is only conserved within
primate genomes, and its homology abruptly drops for
rodents and other non-primate vertebrates. The presence
of the human-specific exon 3 in the OLMALINC-002
isoform further supports the thesis that lincRNAs belong
to rapidly evolving segments of the primate genome [35].
Along with metastasis associated lung adenocarcinoma
transcript 1 (MALAT-1) [36] and polyadenylated nuclear
RNA (PAN) [37], OLMALINC belongs to the exception-
ally abundantly expressed lincRNAs. High expression
levels of some lincRNAs may facilitate their trans function
as a decoy to titrate proteins from their potential targets,
as reported for the growth arrest-specific 5 (Gas5) and
P21 associated ncRNA DNA damage activated (PANDA)
lincRNAs [38,39]. Hence, preservation of a titration
mechanism will require high numbers of lincRNA
molecules interacting with numerous proteins [28].
The RNAi silencing efficiency of OLMALINC was less
effective in neurons than in an oligodendrocytic cell line,
and this could be a result of cell type-specific differences
in the uptake capacity of the siRNA between neurons
and oligodendrocytes [40]. Second, the initial levels of
OLMALINC were much below its expression level in
oligodendrocytes, which further led to diminution of the
silencing effect in neurons.
Silencing of OLMALINC expression in oligodendrocytes
affected the expression of genes, such as SOX4, GPR126
and EGR1, which are involved in the differentiation of
these cells from the neuronal stem lineage and in the
control of myelination processes. Several non-coding
RNAs (ncRNA) have been shown to exhibit dynamic
expression patterns during neuronal and oligodendro-
cyte lineage specification, neuronal-glial fate transi-
tions, and myelination, and they include ncRNAs
associated with differentiation-specific nuclear subdo-
mains, such as Gomafu and Neat1, ncRNAs associated
with developmental enhancers, and genes encoding
important transcription factors and homeotic proteins
[41,42]. Up-regulation of the deacetylase 5 and 9 genes
(Additional file 7: Table S1) by depletion of OLMALINC
further underpins the previous observations of the involve-
ment of lincRNAs in chromatin remodeling-controlling
cellular differentiation, as has been shown in lineage-specific
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cells [43].
The number of genes whose expression was affected
by OLMALINC silencing remains similar to the average
of 175 protein-coding genes that changed their expression
pattern in 137 individual lincRNA knockdowns in
Guttman’s study (2011). Moreover, changes in expression
were characterized by up- and down-regulation, suggest-
ing a versatile impact of OLMALINC on transcription
that leads to the activation or repression of transcription.
This remains in contrast to previous suggestions that the
action of lincRNAs mainly leads to repression of gene
expression [44].Conclusions
Our evidence indicates that the recently evolved
OLMALINC is a primate specific transcript that is a
major contributor to the maintenance of oligodendrocyte
maturation. This conclusion remains in line with previous
observations that lincRNAs are involved in development of
the nervous system [45]. However, it should be emphasized
that further characterization of OLMALINC function will
require systematic studies, including defining all protein
complexes with which the lincRNA possibly interacts,
determining where these protein interactions assemble
on the RNA, and ascertaining whether they bind
simultaneously or alternatively. Moreover, understanding
how OLMALINC–protein or –DNA interactions give rise
to specific patterns of gene expression will require
determination of the functional contribution of each
interaction and possible localization of the complex
to its genomic targets.Methods
Brain tissue and RNA extraction
Samples representing the GM and WM of the human
superior frontal gyrus (SFG) were obtained from the
Sydney Brain Bank following ethical approval from the
Human Research Ethics Committee of the University of
New South Wales. The GM and WM tissues were obtained
from three individuals (aged 79, 94 and 98) without signifi-
cant neuropathology. The post mortem interval (PMI) of
the samples ranged from 8–24 h, and the pH ranged from
5.77-6.65. For RT-qPCR experiments, another two SFG
samples were used that were matched to the previous
samples regarding age, PMI and pH.
Total RNA was extracted from approximately 100 mg
for each case using Qiagen’s RNeasy Lipid Tissue RNA
Extraction Kit. The RNA integrity numbers (RINs) were
determined using an Agilent 2100 BioAnalyzer RNA
Nano Chip. The RIN values ranged from 4.9-7.2. This
RIN range was previously shown to have little effect on
relative gene expression ratios [46].Cell lines
MO3.13 oligodendrocytes and SK-N-SH neurons were
obtained from the ATCC (Manassas, VA) and were
cultured in 12-well plates in Dulbecco’s modified Eagle’s
medium containing 10% fetal calf serum, 2 mM glutamine,
100 IU/ml penicillin, and 100 μg/ml streptomycin at 37°C
in humidified air containing 5% CO2. Cell culture media
and additives were obtained from Invitrogen (Melbourne,
Australia) unless stated otherwise.
Reverse transcription and PCR
Using total RNA samples previously used for the RNA-Seq
analysis [5], the OLMALINC-002, −003 and -AS transcripts
were reverse transcribed and amplified using the Qiagen
One-Step RT-PCR kit. The forward and reverse primers
used to amplify OLMALINC-002 were TGTGGTAC
TAAGCTTGACAGC and TCATAGGTGGATCTCCTC
ACG; for OLMALINC-003, TAGACCTTGCTAACCAG
GACG and TGGTATCAGTTAGCGTGGGGC; and for
OLMALINC-AS, CCCGAGATTCTTTGTGGGCT and CT
CTCCCACCACACACCAC. Standard RT-PCR conditions,
as recommended by Qiagen, were used. PCR products of
560, 1100 and 280 bp were purified and Sanger sequenced.
Quantitative PCR
Primers were designed for the OLMALINC, OLMALINC-AS
and proteasome (prosome, macropain) subunit beta type 4
(PSMB4) genes. For quantification of EGR1, HDAC9, SOX4,
GPR126 and AXL expression in MO3.13 oligodendrocytes
primers were purchased from Qiagen. We used PSMB4 as a
housekeeping gene, as described previously [47]. The PSMB4
forward and reverse primers were ordered from Qiagen
(HS_PSMB4_1_SG QuantiTect primer assay). The sequence
for the OLMALINC forward primer was GACTCCTTTGG
GAGACCAGTG, and that of the reverse primer was
AGGTCACAGGGGATTTGATGG. The OLMALINC
primers spanned the fragment of the transcript that
was common for the OLMALINC-002 and −003 isoforms.
The sequence for the OLMALINC-AS forward primer was
GTCACTGGGGAGAACGTGAC, and that for the
reverse primer was CTCTCCCACCACACACCAC. The
OLMALINC-AS primers were unique for the –AS tran-
script. All of the primers used for RT-qPCR had an effi-
ciency of between 90%-110%. The RNA samples were
reverse-transcribed using the Qiagen QuantiTect Reverse
Transcription (RT) Kit, and the gene expression was
quantified using the QuantiTect SYBR green PCR
master mix (Qiagen). The PCR reaction was performed
on a Rotor-Gene 6000 (Qiagen) using three independent
GM and WM samples and MO3.13 oligodendrocytes, and
each reaction was performed in triplicate. PSMB4 was
used to normalize the results from each RT-qPCR run to
reduce batch effects and correct any variation in template
input [48]. Expression levels were calculated using 2-ΔCt
Mills et al. Molecular Brain  (2015) 8:2 Page 10 of 12and fold-change was calculated using the 2-ΔΔCt method
[49]. Statistically significant changes in gene expression
were assessed using the R project for statistical computing
(www.r-project.org).
RNA interference
RNAi knockdown of OLMALINC was carried out using
four commercially prepared siRNA oligonucleotides
(Qiagen) specific to different fragments of the OLMALINC
transcript. Briefly, MO3.13 and SK-N-SH cells were seeded
at 40% confluence in 6-well plates in antibiotic-free media
and equimolar mix of four oligonucleotides was transfected
using Lipofectamine 2000 and Opti-MEM I (Invitrogen)
following the manufacturer’s protocol. For validation exper-
iments MO3.13 oligodendrocytes were transfected with
two individual siRNAs used previously in the four siRNA
mix. Transfection efficiency was confirmed by substituting
the siRNA with fluorescently labelled BLOCK-iT reagent
(Invitrogen), using the same transfection procedure and this
confirmed >95% transfection efficiency was achieved as
assessed by fluorescence microscopy.
RNA isolation, library preparation and sequencing
After 48 hrs of culture total RNA was isolated using
RNeasy Mini Kit (Qiagen) followed by RNase-free
DNase treatment to remove traces of genomic DNA.
The RNA quality of the total RNA was assessed using
the Agilent 2100 BioAnalyser RNA Nano Chip and the
RIN values ranged between 8.0 and 9.0. Six RNA samples
(three MO3.13 and three SK-N-SH replicates) were pre-
pared for sequencing according to the Illumina TruSeq
RNA sample preparation guide and subjected to 100 bp
paired-end sequencing using Illumina HiSeq1000.
Meta-analysis of Illumina expression data of non-brain
tissues
Meta-analysis of Illumina BodyMap2 transcriptome files
was carried out to determine the expression distribution
of OLMALINC across tissues at the gene level. The
BodyMap2 project was carried out by Illumina to pro-
vide a sample RNA-Seq dataset of 16 individual and
mixed tissues. A second analysis was performed on five
independent RNA-Seq datasets produced by The Human
Protein Atlas (http://www.proteinatlas.org/tissue). The
meta-analysis was carried out on Galaxy using the Tuxedo
protocol [13], and files from Illumina’s BodyMap2
project and the Human protein Atlas project were
imported into Galaxy from the NCBI sequence read
archive (SRA) (project accession number: ERP000546,
http://www.ncbi.nlm.nih.gov/sra/?term=ERP000546, project
accession number: ERP003613, http://www.ncbi.nlm.nih.
gov/sra/?term=ERP003613). The selected SRA file reads
were assembled with TopHat, which utilizes Bowtie to align
short sequence reads to the H. sapiens reference genome(build hg19). The default setting for TopHat was used.
Cufflinks was then used to assemble the aligned reads into
individual transcripts by inferring splicing structure and
provided a minimal number of predicted transcripts
through parsimonious assembly. Cufflinks also normalized
the read count of each input file to allow for calculation
of the relative abundance of each transcript in fpkm. To
guide the assembly process, the iGenomes UCSC hg19 full
annotation GTF file was used. These steps were performed
for all 16 tissue types that were assessed. Subsequently, the
results for each tissue type were merged with the files for
the brain transcriptome and the iGenomes reference anno-
tation via Cuffmerge and then passed through Cuffdiff.Comparative analysis with vertebrate genomes
The UCSC Genome Browser website (http://genome.ucsc.
edu/index.html) contains the reference sequences and
working draft assemblies of a large collection of genomes
from a variety of organisms. Using the UCSC Genome
Browser, the level of sequence conservation of OLMALINC
across numerous species was analyzed.Gene ontology enrichment analysis
The lists of DEGs and DEIs were entered into the Database
for Annotation, Visualization and Integrated Discovery
(DAVID) (http://david.abcc.ncifcrf.gov/) [50]. DAVID
can only utilize annotated genes/isoforms; thus, all
un-annotated genes/isoforms and indecisively annotated
genes/isoforms were removed from the lists. DAVID tests
GO terms for over representation in each of the DEG and
DEI lists. The GO terms lost produced by DAVID, were
processed using the ‘Enrichment Map’ plug in for
‘Cytoscape’ (http://www.cytoscape.org/) [51]. This produces
a visual putput of the text based GO term lists.Data access
The sequence data have been submitted to the NCBI
Short Read Archive with accession number SRA602249.Additional files
Additional file 1: Figure S1. Differential expression of the OLMALINC
gene and its isoforms as revealed by RNA-Seq analysis of GM and WM
samples from the human frontal cortex. (A) Expression levels of the
OLMALINC gene in GM and WM. (B) Expression levels of the OLMALINC-002
and −003 isoforms in GM and WM; bars represent SD. Level of significance:
**q-value< 0.02, ***q-value<0.01.
Additional file 2: Figure S2. Sequence alignment of Sanger sequenced
RT-PCR OLMALINC products with sequences derived from RNA-Seq data.
The query sequence is the sequence derived from Sanger sequencing
and the subject sequence is derived from RNA-Seq data. A. Sequence
alignment of OLMALINC-002. B. Sequence alignment of OLMALINC-003
C. Sequence alignment of OLMALINC-AS. The letter N marks
nucleotides where sequencing failed to develop a consensus
sequence.
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chimpanzee, gorilla, orangutan, rhesus monkey, marmoset and opossum
genomes with blat searches on the UCSC genome browser. All
homologies are displayed relative to the SCD gene. In the opossum
genome (reverse orientation) homology to exon 1 was not detected with
blat searches, but was detected in the multiZ alignments track. In rhesus
monkey, exon 3 is not detected in the correct position with balt
searches, but is detected with blastz. Exon 1 homologies are boxed in
red, exon 2 in green, and exon 3 in blue. Basewise conservation
calculated by PhyloP across 100 vertebrates shows a peak in conservation
upstream of OLMALINC exon 1 indicated a possible promoter region.
Additional file 4: Figure S4. Read coverage from male brain RNA-seq
data across the OLMALINC homologous regions in human, chimpanzee,
gorilla, orangutan, rhesus monkey and opossum. Outside of great apes
there is no evidence for expression of any exon. Exon 1 homologies are
boxed in red, exon 2 in green, and exon 3 in blue. Read depth bedGraph
files were available for human, gorilla, rhesus monkey and opossum [11].
For chimpanzee and orangutan, RNA-seq reads [12] were mapped with
TopHat v2.0.9 with the command line options: tophat -p 4 -a 8 -i 40 -m 1
-I 1000000 –coverage-search –microexon-search. Read depth coverage
bedGraph files were generated with the samtools depth utility.
Additional file 5: Figure S5. Comparative analysis of OLMALINC
expression across five tissue samples. The RNA-Seq data sets were taken
from the Human Protein Atlas project (http://www.proteinatlas.org/).
Again, OLMALINC is expressed at its highest level in brain tissue and it is
expressed 3-fold higher than liver, the tissue source with the next highest
level of expression. The independent dataset confirms the results from
Figure 4. The y-axis is expression in fpkm.
Additional file 6: Figure S6. Quantification of the OLMALINC transcript
following its knockdown in oligodendrocytes and neurons using
RT-qPCR. OLMALINC levels in oligodendrocytes and neurons were reduced
by 4.5- and 3.5-fold, respectively (p-values<0.05). N – neurons; O –
oligodendrocytes.
Additional file 7: Table S1. Full list of differentially expressed genes
and isoforms between the oligodendrocyte cell controls and the
oligodendrocyte cells that underwent RNAi.
Additional file 8: Table S2. Full list of differentially expressed genes
and isoforms between the neuronal cell controls and the neuronal cells
that underwent RNAi.
Additional file 9: Table S3. Enriched gene ontology terms for genes
and isoforms differentially expressed in the oligodendrocyte cell line.
Additional file 10: Figure S7. RT-qPCR validation of the EGR1, HDAC9,
SOX4, AXL and GPR126 genes expression pattern in MO3.13
oligodendrocytes silenced with individual OLMALINC siRNAs. EGR1,
HDAC9 and SOX4 genes were up-regulated 4-, 4.4-, 3.6-fold in RNAi-treated
oligodendrocytes when compared to control (p-value<0.05), respectively.
The GPR126 and AXL genes were down-regulated 3.5- and 7.5-, respectively.
Con – control.
Additional file 11: Table S4. Enriched gene ontology terms for genes
and isoforms differentially expressed in the neuronal cell line.
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